Trial Profile
Healthcare Utilization and Cost Burden in Patients with Severe Asthma Receiving Fluticasone Propionate or Salmeterol/Fluticasone Propionate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 09 May 2011 New trial record
- 22 Mar 2011 Results presented at the 67th Annual Meeting of the American Academy of Allergy, Asthma and Immunology